首页> 美国卫生研究院文献>Oncotarget >Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy
【2h】

Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy

机译:明确放化疗治疗的食管癌患者的治疗前营养风险评分和表现状态是预后因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study evaluated the prognostic effects of nutritional risk scores and performance status (PS) on unresectable locally advanced esophageal cancer (LAEC) patients who were treated with definitive concurrent chemoradiotherapy (dCRT). A total of 202 LAEC patients from four different cancer centers were retrospectively reviewed. Nutritional risk and PS were measured using the Nutritional Risk Screening 2002 (NRS-2002) scores and Eastern Cooperative Oncology Group (ECOG) scales. Outcomes were clinical response rate, overall survival (OS) and progression-free survival (PFS). Multivariate analysis of predictive factors of response to dCRT and survival were performed using a logistic regression and a Cox model, respectively. The majority of patients (71.8%) had an ECOG PS score of 0-1, and 52.5% (n=106) of patients were identified as having nutritional risk (NRS-2002 ≥3) upon treatment initiation. There was no correlation between NRS-2002 scores and ECOG PS (Spearman's ρ=0.046; P=0.516). In multivariate analysis, NRS-2002 scores (P=0.002, HR 2.805, 95%CI: 1.445-5.446) and ECOG PS (P=0.015, HR 2.719, 95%CI: 1.218-6.067) were independent prognostic factors for the response to dCRT. NRS-2002 scores (OS: HR 1.530, 95%CI 1.059-2.209; P=0.023; PFS: HR 1.517, 95%CI 1.105-2.082; P=0.010) and ECOG PS (OS: HR 1.729, 95%CI 1.185-2.522; P=0.005; PFS: HR 1.678, 95%CI 1.179-2.387; P=0.004) were both independent prognostic factors for OS and PFS. In conclusions, NRS-2002 scores and ECOG PS scales both have prognostic effects on clinical response and survival in LAEC, but a significant association of NRS-2002 scores and ECOG PS were not observed.
机译:这项研究评估了营养风险评分和表现状态(PS)对接受明确同时放化疗(dCRT)治疗的不可切除的局部晚期食管癌(LAEC)患者的预后影响。回顾性分析了来自四个不同癌症中心的202名LAEC患者。使用2002年《营养风险筛查》(NRS-2002)评分和东部合作肿瘤小组(ECOG)量表测量营养风险和PS。结果是临床反应率,总生存期(OS)和无进展生存期(PFS)。使用Logistic回归和Cox模型分别对dCRT和生存率的预测因素进行多变量分析。大多数患者(71.8%)的ECOG PS评分为0-1,并且52.5%(n = 106)的患者在治疗开始后被确定具有营养风险(NRS-2002≥3)。 NRS-2002评分与ECOG PS之间没有相关性(Spearman的p = 0.046; P = 0.516)。在多变量分析中,NRS-2002评分(P = 0.002,HR 2.805,95%CI:1.445-5.446)和ECOG PS(P = 0.015,HR 2.719,95%CI:1.218-6.067)是反应的独立预后因素。到dCRT。 NRS-2002分数(OS:HR 1.530,95%CI 1.059-2.209; P = 0.023; PFS:HR 1.517,95%CI 1.105-2.082; P = 0.010)和ECOG PS(OS:HR 1.729,95%CI 1.185 -2.522; P = 0.005; PFS:HR 1.678,95%CI 1.179-2.387; P = 0.004)均为OS和PFS的独立预后因素。结论是,NRS-2002评分和ECOG PS量表均对LAEC的临床反应和生存有预后影响,但未观察到NRS-2002评分与ECOG PS的显着相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号